SCHEMBL8205476

SCHEMBL8205476

COc1ncc(-c2nn(C)nc2-c2ccccc2)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.48
CYP1A2 P05177 10/20 0.48
HSD17B10 Q99714 10/20 0.48
MAPK1 P28482 2/20 0.43
CYP3A4 P08684 7/20 0.42
CYP2C9 P11712 5/20 0.42
CASP1 P29466 5/20 0.41
USP2 O75604 4/20 0.41
CASP7 P55210 3/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2D6 P10635 2/20 0.40
GLA P06280 1/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40
GRM5 P41594 1/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13510686 0.84 ALDH1A1 (0.43) ALDH1A1CYP1A2HSD17B10MAPK1CYP3A4
SCHEMBL13509083 0.84 ALDH1A1 (0.43) ALDH1A1CYP1A2HSD17B10MAPK1CYP3A4
SCHEMBL8215862 0.81 KDR (0.48) HSD17B10MEN1KMT2AGRM5HPGD
SCHEMBL8205966 0.80 KMT2A (0.48) ALDH1A1HSD17B10MAPK1CASP1USP2
SCHEMBL8218208 0.77 KDM4E (0.61) ALDH1A1MAPTMEN1KMT2AATM
SCHEMBL16225052 0.73 ALOX5AP (0.49) ALDH1A1CYP1A2HSD17B10CASP1MAPT
SCHEMBL2325961 0.72 ADORA2A (0.65)
SCHEMBL8214146 0.70 NUDT14 (0.50) ALDH1A1MAPTTSHRKDM4ELMNA
SCHEMBL8206858 0.70 KDM4E (0.41) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL15958639 0.70 KDM4E (0.51) ALDH1A1CYP1A2HSD17B10MAPK1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021960-A2 TRIAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-02-21 WO disclosed